tirzepatide in mash π΄ #SYNERGY_NASH Trial (NEJM, 2024) for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis π this phase 2 trial involving participants with and moderate or severe fibrosis, treatment with tirzepatide for Drug treatment of MASH from
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21




























